2017
A systematic analysis of FDA-approved anticancer drugs
Sun J, Wei Q, Zhou Y, Wang J, Liu Q, Xu H. A systematic analysis of FDA-approved anticancer drugs. BMC Systems Biology 2017, 11: 87. PMID: 28984210, PMCID: PMC5629554, DOI: 10.1186/s12918-017-0464-7.Peer-Reviewed Original ResearchConceptsDrug-cancer associationsAnticancer drugsTarget-based drugsEfficient anticancer drugsTarget-based approachCancer typesNew anticancer drugsNovel anticancer drugsClinical trial studyPharmaceutical researchTrial studyMore cancer typesUS FoodDrug AdministrationCytotoxic drugsPatient treatmentPotential candidateDrug mechanismsDrugsDrug repurposingSystematic investigationAssociationDrug targetsTyrosine kinaseSystematic discovery
2016
A new method for the synthesis of β-cyano substituted porphyrins and their use as sensitizers in photoelectrochemical devices
Antoniuk-Pablant A, Terazono Y, Brennan B, Sherman B, Megiatto J, Brudvig G, Moore A, Moore T, Gust D. A new method for the synthesis of β-cyano substituted porphyrins and their use as sensitizers in photoelectrochemical devices. Journal Of Materials Chemistry A 2016, 4: 2976-2985. DOI: 10.1039/c5ta07226c.Peer-Reviewed Original ResearchPhotoelectrosynthetic cellsWater oxidationNew synthetic methodSolar cellsSensitive functional groupsHigh positive potentialsElectrochemical propertiesRedox mediatorSynthetic methodZinc porphyrinMost porphyrinsPhotoelectrochemical devicesFunctional groupsMild conditionsPresence of TrisPorphyrinsPotential candidateNanoparticulate TiOSensitizersOxidationPositive potentialsDyeMoleculesImproved yieldPhotocurrent
2012
Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer
Meng L, Yang L, Zhao X, Zhang L, Zhu H, Liu C, Tan W. Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer. PLOS ONE 2012, 7: e33434. PMID: 22558072, PMCID: PMC3338807, DOI: 10.1371/journal.pone.0033434.Peer-Reviewed Original ResearchConceptsAptamer-drug conjugatesCancer-specific aptamersAntitumor agent doxorubicinDOX conjugatesIntercalation methodAptamerCell viability testTargeted deliveryConjugatesCancer cellsTarget proteinsAgent doxorubicinPotential candidateCell linesDOXEfficiency of chemotherapyLiver cancer cellsNonspecific uptakeTarget specificityAvailable aptamersCarcinoma cell linesChemotherapy agentsHepatocellular carcinoma cell linesHuman hepatocellular carcinoma cell linePromising method
2001
Synthesis of potent and selective dopamine D4 antagonists as candidate radioligands
Huang Y, Kegeles L, Bae S, Hwang D, Roth B, Savage J, Laruelle M. Synthesis of potent and selective dopamine D4 antagonists as candidate radioligands. Bioorganic & Medicinal Chemistry Letters 2001, 11: 1375-1377. PMID: 11378358, DOI: 10.1016/s0960-894x(01)00241-4.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply